BKR Form 144: Proposed sale of 50,362 Class A shares ($2.36M)
Form 144 filing by a person associated with Baker Hughes Company (BKR) discloses a proposed sale of 50,362 Class A shares through Fidelity Brokerage Services with an aggregate market value of $2,361,474.18.
Rhea-AI Filing Summary
Form 144 filing by a person associated with Baker Hughes Company (BKR) discloses a proposed sale of 50,362 Class A shares through Fidelity Brokerage Services with an aggregate market value of $2,361,474.18. The filing lists approximately 985,879,124 Class A shares outstanding and indicates an approximate sale date of 09/10/2025 on NASDAQ. The securities were acquired as options granted on 07/31/2017 and are scheduled to be sold for cash; the acquisition and payment entries both reference the date 09/10/2025. The filing also reports a prior sale by Maria Borras of 5,585 Class A shares on 06/17/2025 for gross proceeds of $223,400.00. The filer attests they are not aware of undisclosed material adverse information and includes the standard Rule 10b5-1 and signature attestations.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Section 144 notice for an insider option sale; size appears immaterial relative to outstanding shares.
The filing documents a proposed public sale of 50,362 Class A shares valued at $2.36 million via Fidelity on NASDAQ, arising from options granted in 2017 and to be sold for cash on 09/10/2025. With 985.9 million shares outstanding the proposed sale represents a very small fraction of total equity. The filing follows required disclosure protocols under Rule 144 and notes a recent smaller sale by Maria Borras on 06/17/2025. From a market-impact perspective this is routine insider liquidity rather than a material issuance or corporate action.
TL;DR: Proper Form 144 mechanics and attestations are present; no indication of undisclosed material information.
The document includes the standard attestations about absence of undisclosed material adverse information and references to potential reliance on a Rule 10b5-1 plan. It specifies the nature of acquisition (options granted 07/31/2017) and payment in cash, which are appropriate disclosures for an officer/director or other affiliate disposing of restricted securities. Nothing in the filing indicates a governance event such as a departure, issuance, or material corporate change.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filed for Baker Hughes (BKR) disclose?
Does the filing mention prior sales by the seller?
Does the filer attest to having undisclosed material information?
AI-generated analysis. How Rhea-AI works. Not financial advice.